Blood-based RBBP7 and RIBC1 methylation as a candidate epigenetic biomarker for ovarian cancer epigenetic markers RBBP7 and RIBC1 in ovarian cancer

2026/07/29 by Özge Şükrüoğlu Erdoğan, Seda Kılıç, Seda Kılıç Erciyas +13
Biochemistry, Genetics and Molecular Biology · Medicine · #Biomarker #Cancer #Cancer Cells and Metastasis #Cancer-related gene regulation #DNA methylation #Disease #Epigenetics #Epigenetics and DNA Methylation #Methylation #Ovarian cancer

paper · doi:10.1007/s11033-026-12485-4

published in Molecular Biology Reports 53(1) (Springer Nature)

openalex publication_date 2026/07/29 · openalex created_date 2026/07/30 · openalex updated_date 2026/07/31

Citations

• Mucinous Ovarian Carcinoma
• Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction
• Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries